Stocks and Investing
Stocks and Investing
Tue, April 30, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Initiated (avbp) at Strong Buy and Held Target at $25 on, Apr 30th, 2024
Robert Burns of HC Wainwright & Co., Initiated "ArriVent BioPharma, Inc." (AVBP) at Strong Buy and Held Target at $25 on, Apr 30th, 2024.
Robert has made no other calls on AVBP in the last 4 months.
There are 3 other peers that have a rating on AVBP. Out of the 3 peers that are also analyzing AVBP, 0 agree with Robert's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Robert
- Corinne Johnson of "Goldman Sachs" Initiated at Strong Buy and Held Target at $27 on, Tuesday, February 20th, 2024
- Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $35 on, Tuesday, February 20th, 2024
- Yigal Nochomovitz of "Citigroup" Initiated at Strong Buy and Held Target at $30 on, Tuesday, February 20th, 2024
Contributing Sources